XOMA Royalty (XOMA) Assets Average (2011 - 2026)
XOMA Royalty (XOMA) reported Assets Average of $272.3 million for Q1 2026, up 25.47% on a YoY basis from $217.0 million in Q1 2025, and up 24.84% sequentially from $218.1 million in Q2 2025.
XOMA Royalty (XOMA) Assets Average (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of Assets Average data on file, last reported at $272.3 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 25.47% year-over-year to $272.3 million; the trailing twelve-month figure through Mar 2026 stood at $272.3 million (up 25.47% YoY), and the FY2025 full-year result was $247.0 million, up 8.43% from the prior year.
- Assets Average grew to $272.3 million in Q1 2026, from $218.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $272.3 million in Q1 2026 to a low of $124.9 million in Q3 2023.
- A 5-year average of $187.0 million and a median of $179.2 million in 2023 frame the typical range for Assets Average.
- Across the five-year window, Assets Average fell 17.25% in 2023 and surged 86.83% in 2024, its largest moves.
- Tracing XOMA's Assets Average over 5 years: stood at $143.3 million in 2022, then increased by 25.09% to $179.2 million in 2023, then increased by 24.06% to $222.3 million in 2024, then dropped by 1.89% to $218.1 million in 2025, then grew by 24.84% to $272.3 million in 2026.
- Business Quant data shows XOMA's Assets Average at $272.3 million in Q1 2026, $218.1 million in Q2 2025, and $217.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 272.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272.28 Mn |
| Jun 30, 2025 | 218.10 Mn |
| Mar 31, 2025 | 217.01 Mn |
| Dec 31, 2024 | 222.31 Mn |
| Sep 30, 2024 | 233.31 Mn |
| Jun 30, 2024 | 231.35 Mn |
| Mar 31, 2024 | 226.86 Mn |
| Dec 31, 2023 | 179.20 Mn |
| Sep 30, 2023 | 124.88 Mn |
| Jun 30, 2023 | 129.66 Mn |
| Mar 31, 2023 | 137.02 Mn |
| Dec 31, 2022 | 143.26 Mn |
| Sep 30, 2022 | 150.18 Mn |
| Jun 30, 2022 | 156.69 Mn |
| Mar 31, 2022 | 162.86 Mn |
| Dec 31, 2021 | 148.53 Mn |
| Sep 30, 2021 | 133.13 Mn |
| Jun 30, 2021 | 127.82 Mn |
| Mar 31, 2021 | 122.59 Mn |
| Dec 31, 2020 | 105.51 Mn |